# Study to Evaluate the Ocular Tolerance of SYL1001 in Healthy Volunteers

> **NCT01438281** · PHASE1 · COMPLETED · sponsor: **Sylentis, S.A.** · enrollment: 30 (actual)

## Conditions studied

- Ocular Pain
- Dry Eye

## Interventions

- **DRUG:** SYL1001

## Key facts

- **NCT ID:** NCT01438281
- **Lead sponsor:** Sylentis, S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2011-11
- **Final completion:** 2012-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2012-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01438281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01438281, "Study to Evaluate the Ocular Tolerance of SYL1001 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01438281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*